#JustPublished!
A joint #ECDC - @EMA_News statement on updating #COVID19 vaccines composition for new #SARSCoV2 virus variants.
Read full here:
https://bit.ly/42wARAa
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1666384463536824321
In line with the outcome of recent meetings of international regulators and the @WHO, @EMA_News Emergency Task Force recommends updating vaccines to target #XBB strains (a subgroup of #Omicron), which have become dominant in Europe and other parts of the world.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1666384473032736768
Both agencies (@ECDC_EU & @EMA_News) note that monovalent vaccines (vaccines targeting only one strain such as XBB.1.5) are a reasonable choice to provide protection against current dominant and emerging strains.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1666384475800969217
Timely vaccination ahead of a potential autumn and winter 2023 surge of #COVID19 cases is essential for protecting people from severe COVID-19 and health systems from being overwhelmed.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1666384479747809280
Currently authorised vaccines continue to be effective at preventing hospitalisation, severe disease and death due to #COVID19.
However, protection against the virus declines over time as new #SARSCoV2 variants emerge.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1666384468662157313